The Medical Advisor

Introduction: America’s Metabolic Disease Crisis Is Not a Medical Mystery America is not losing the fight against metabolic disease because of a lack of medications, calorie labels, or dietary advice. It is losing because it keeps treating a systems-level biological failure as an individual behavioral problem. Today, more than 9 in 10 American adults show at least one marker of metabolic dysfunction—insulin resistance, obesity, hypertension, dyslipidemia, or impaired glucose tolerance. Type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), and metabolic syndrome are no longer exceptions. They are the baseline. The medical system responds downstream: glucose-lowering drugs, statins, blood pressure medications, and—more recently—GLP-1 agonists. These tools can be helpful. But they operate far downstream from the original biological insult. What if the metabolic disease epidemic does not begin in the pancreas, liver, or adipose tissue? What if it beg...